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Abstract
Backgound: The male-specific region of chromosome-Y (MSY) contributes to phenotypes outside of testis
development and has a high rate of evolution between mammalian species. With a lack of genomic crossover, MSY
is one of the few genomic areas under similar variation and evolutionary selection in inbred and outbred animal
populations, allowing for an assessment of evolutionary mechanisms to translate between the populations.
Methods: Using next-generation sequencing, MSY consomic strains, molecular characterization, and large-scale
phenotyping, we present here regions of MSY that contribute to inbred strain phenotypes.
Results: We have shown that (1) MSY of rat has nine autosomal gene transposition events with strain-specific
selection; (2) sequence variants in MSY occur with a 1.98-fold higher number of variants than other chromosomes
in seven sequenced rat strains; (3) Sry, the most studied MSY gene, has undergone extensive gene duplications,
driving ubiquitous expression not seen in human or mouse; (4) the expression profile of Sry in the rat is driven by
the insertion of the Sry2 copy into an intron of the ubiquitously expressed Kdm5d gene in antisense orientation,
but due to several loss of function mutations in the Sry2 protein, nuclear localization and transcriptional control are
decreased; (5) expression of Sry copies other than Sry2 in the rat overlaps with the expression profile for human SRY;
(6) gene duplications and sequence variants (P76T) of Sry can be selected for phenotypes such as high blood
pressure and androgen receptor signaling within inbred mating; and most importantly, (7) per chromosome size,
MSY contributes to higher strain-specific phenotypic variation relative to all other chromosomes, with 53
phenotypes showing both a male to female and consomic cross significance.
Conclusion: The data presented supports a high probability of MSY genetic variation altering a broad range of
inbred rat phenotypes.
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Background
Recent analysis of the male-specific region of
chromosome-Y (MSY) has identified a core set of genes
found throughout mammalian evolution [1]. While
many of these genes contribute to classical sex
determination and testis function in mammals, they add-
itionally contribute to the maintenance of X-Y gene ex-
pression levels and numerous sex disparities in diseases
[2, 3]. The association of human age-related loss of MSY
with mortality age in males [4], in combination with a
ubiquitous expression profile for several human MSY
genes [3], signifies functional importance of genes resid-
ing on MSY to normal biological functions outside of
sex determination. Disease associations for MSY include
cardiovascular disorders, asthma, autoimmune disorders,
birth defects, neurological/psychiatric disorders (includ-
ing schizophrenia and Parkinson disease), and many
cancers [3, 5]. Due to the lack of the MSY to undergo re-
combination, it is one of the largest linkage disequilib-
rium (LD) blocks within the human genome; therefore,
identifying the causal variants from haplotypes is very
difficult using human genomics alone, making it as diffi-
cult as autosomal variant analysis before the completion
of the 1000 Genomes Project. With the complex genet-
ics of the MSY, research into this field has also been slo-
wed by the lack of animal congenic mapping and the
lack of high-throughput characterizations in MSY animal
consomic models.
However, the high mutation rate within MSY and an
identical inheritance pathway between outbred and in-
bred animals could allow for comparative genomics in
animal models to help identify MSY genes that are in-
volved in phenotypes outside of sex determination, and
therefore could be used to look for variants in human
that contribute to disease. To date, no animal models
with both genetics and high-throughput phenotyping
have been developed to study these broad phenotypic
contributions of MSY genetics.
Sex differences in cardiovascular disease have been
shown previously [6]. MSY haplotypes in human correl-
ate with increased risk of coronary artery disease and
blood pressure [7, 8]. The rat (Rattus norvegicus) has
been a model organism for MSY contributions to blood
pressure regulation for 25 years [9], but has lacked MSY
sequence information until 2014, making it impossible
to determine mechanisms of MSY phenotypic contribu-
tions. Consomic rats generated introgressing MSY be-
tween common strains of rats by our group and others
for SHR to WKY [10], WKY to SHR [10], SHRSP to
WKY [11], BN to SHR [12], BN to FHH [13], and BN to
SS [14] have suggested strain-specific contributions of
the rat MSY to blood pressure and kidney function (Fig.
1, strain abbreviations can be found in the figure). An
interplay between MSY and androgen receptor signaling
has been previously suggested for the SHR blood pres-
sure regulation [10]. An F1 cross of the SHR/y (consomic
of the SHR MSY onto WKY autosomes) to the testicular
feminized rat (Tfm) repressed the role of MSY on blood
pressure [10], but no understanding of the mechanisms
behind this has yet been discovered.
Due to a high mutation rate of MSY, combined with a
lack of chromosomal crossover, it is hypothesized that
many inbred rat strains have had genetic variants on MSY
selected upon for phenotypic traits such as blood pressure.
These genetic variants of rat MSY may influence similar
genes as those involved in human disease or MSY evolu-
tion throughout speciation, allowing researchers to nar-
row down the large human haplotype block to individual
genes involved in these processes. As the rat commonly
serves as a model for understanding sex differences
through hormones, it is critical to define the genetics of
strain-specific changes that may also serve to alter sex dif-
ferences, resulting in a fuller understanding of both gen-
etic and hormone contributions to sex differences in our
model organisms. Therefore, we have undertaken an ana-
lysis of MSY genes in the most commonly researched
strains of rat, which have previously had autosomal ge-
nomes sequenced [15]. The characterization of genes
within rat MSY, variants within multiple inbred lines, mo-
lecular characterization of several protein-coding variants,
and a large-scale analysis of MSY phenotyping for several
strains will contribute to future development of animal
models to study the role of MSY genes.
Methods
RNAseq analysis for Sry and other chromosome-Y genes
Analysis of RNAseq datasets for Sry was initially per-
formed on publically available RNAseq datasets in NCBI
for R. norvegicus differentiating Sry2 from the other Sry
copies. This was performed using the Sequence Read
Archive (SRA) Nucleotide BLAST tool of NCBI opti-
mized for megablast using Not_Sry2, Not_Sry2_2, Sry2,
and Sry2_2 sequences of Additional file 1: Table S1. All
positive reads were 100 % homologous with an E-value
<9e−12. Positive reads for each RNAseq experiment
were normalized with total number of reads in the SRA
file and shown as reads per million (RPM). BLAST ana-
lysis was also performed using the Rat BodyMap datasets
of the Fischer 344 rat RNAseq for 11 tissues of four ages
in both males and females [16]. Additional sequences for
Sry copy specificity (Additional file 1: Table S1) were
used in the analysis to determine relative expression of
each copy. The single-nucleotide variants (SNVs) in
these sequences were placed in the middle or on the
ends of the sequence such that reads with 100 % hom-
ology and an E-value <9e−12 all contained the SNV.
One female genome (LE- ERR224452) was used as a
negative control for all MSY variant sites.
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Utilizing the SNVs in the male to female genome ana-
lyses below, SNVs were identified that are within 20
bases of each other for the various male-specific SNVs.
These sites then had a BLAST analysis done against
HTGS files of the rat to confirm they are present on
chromosome-Y BAC sequences. Then using these se-
quences with the SNVs (Additional file 1: Table S1), the
160 male RNAseq files of the Rat BodyMap were ana-
lyzed for tissue expression using BLAST with the above
parameters.
Analysis of whole-genome sequencing data for
chromosome-Y SNVs and indels
The DNA of seven male rat genomes (ACI, FHH, FHL,
SBH, SBN, SR, and SS) was sequenced with the Illumina
HiSeq2000 platform (Illumina, Inc., San Diego, CA) at
the Medical College of Wisconsin. The Rnor_6.0 rat
assembly containing the SHR/Akr chromosome-Y was ob-
tained and indexed with BWA (version 0.7.7). Paired-end
reads of each male rat genome were aligned to Rnor_6.0
reference sequences with BWA-MEM (version 0.7.7).
Read pairing information and flags in the alignment were
further cleaned up with fixmate in SAMtools (version 1.1).
Duplicates were marked with Picard (version 1.108) prior
to variant detection. Variants were called using the
Genome Analysis Toolkit (GATK) UnifiedGenotyper
(version 3.2.2) with the parameter setting suggested by the
best practice (https://www.broadinstitute.org/gatk/guide/
best-practices?bpm=DNAseq).
DNA analysis for chromosome-Y genes in multiple rat
strains
Analysis of Sry copies in genomic DNA reads of eight
male rat strains (SHR- ERR224462, WKY- ERR224468,
FHH- ERX199109, FHL- ERX199110, ACI- ERX199106,
SR- ERX199124, SS- ERX199126, Fischer 344- ERR224448)
was performed by BLAST analysis of SRA files using
Sry-specific SNVs to differentiate the multiple copies
(Additional file 1: Table S1). One female genome (LE-
ERR224452) was used as a negative control.
Whole-genome sequence reads from 20 inbred rat
strains (BBDP, LE/Stm, MHS, MNS, WAG, ACI, F344/
NCrl, FHH, FHL, LEW, LEW/NClrBR, LH, LL, LN,
SBH, SBN, SHRSP/Gla, SR/Jr, SS/Jr, SS_JrHsdMcwi)
were aligned to the rat reference genome Rnor_5.0
(lacking MSY) using BWA, and SNVs were identified in
all samples using GATK. The ratio of alternative to ref-
erence reads in each strain was calculated from the
GATK variant calls to determine zygosity at each locus.
With a compiled list of SNVs, we also determined if the
genomic DNA sequenced for each of these 20 strains
was male (and male contaminated female) or female
with BLAST analysis of the reads using the Sry1 coding
sequence. In order to identify male-specific SNVs in the
whole genome, those genomes that were female were
then set to allele frequency of 0 % for SNVs while the
male genomes were set to anything between 0.1 and
99.9 %. Additionally, we choose to identify strain-
specific SNVs in the males again using 0 % allele fre-
quency for the female genomes, setting one male allele
frequency at a time to 0 %, and setting all other male
allele frequency to 0.1–99.9 %. For each variant, the
average allele frequency was calculated for all male rat
strains for each SNV and then averaged over the mul-
tiple SNVs located within a single gene, calculating the
standard error of the mean (SEM) of the later.
Sry expression using real-time PCR and fragment analysis
Male 15–20-week-old rats were anesthetized by intra-
muscular injection of 2.5 % sodium pentothal at a con-
centration of 2 μL per gram body weight and then
terminated by decapitation. Tissues were isolated and
Fig. 1 MSY consomic rats that have been generated. Crosses of male (♂) and female (♀) rat strains have generated six different MSY consomic
strains. Abbreviations for rat strains are shown in the first box. Phenotyping of the animal was performed at the designated generation (F11, F2, F9)
relative to a male from the strain designated in a circle. For two of the consomic strains, they were crossed with the Tfm rat, containing a loss of
function androgen receptor mutation, to assess the segregation of blood pressure contributions due to MSY vs. MSY and hormone signaling
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stored at −80 °C until use. RNA was isolated using RNA
STAT 60 (Tel-Test Inc, Friendswood, TX) and precipi-
tated with isopropanol. The removal of residual DNA
from RNA samples by DNase was carried out using
TURBO DNA-free DNase enzyme (Ambion, Waltham,
MA). RNA concentration and quality was determined
with a Nanodrop ND-1000 Spectrophotometer. Reverse
transcription of RNA was performed with ArrayScript
Reverse Transcriptase (Ambion) and RtallS-A primer
(5′- GGACAGTAAGTAGGTTAGCT-3′) that is Sry and
strand specific. Real-time PCR was performed with
SYBR Green (Applied Biosystems, Waltham, MA) using
Sry L (5′-GCG CCC CAT GAA TGC AT-3′) and Sry R
(5′-TGG GAT TCT GTT GAG CCA ACT-3′) primer
set on an ABI Prism 7700 Real-Time PCR System. ΔCT
values were analyzed via two-way ANOVA, tissue by
strain with age and rat number as random effects,
followed by Tukey post hoc test. Differences were con-
sidered significant at P < 0.05. Fragment analysis was
performed as previously described [17]. In short, using
the cDNA of above following by PCR reactions with
GoTaq Flexi DNA Polymerase (Promega, Fitchburg, WI)
with 5'S2L (5′-CCA TCT CTG ACT TCC TGG TTG-
3′) and RtallS-B (5′-AGT AGG TTA GCT GCT GCT
AG-3′) primers. The amplicon was then labeled with
three separate PCR reactions to differentiate the copies
using NED-*P1mod(5′-GAA TGC ATT TAT GGT GTG
GTC CCG-3′) with S1502G1rev(5′-TAG TGG AAC
TGG TGC TGC TG-3′), dCAP-Sry1 HindIII(5′-AGA
ATT CAG AGA TCA GCA AGC T-3′) with
S1502G1rev*-VIC(5′-TAG TGG AAC TGG TGC TGC
TG-3′), and 5'S2L with M1*-FAM(5′-TTT GTT GAG
GCA ACT TCA CGC TGC-3′). The dCAP reaction
was digested with HinfI restriction enzyme. Samples
were run on an Applied Biosystems 3130xl Genetic
Analyzer using 5.5 % v/v GeneScan LIZ 600 sizing
standard (Applied Biosystems). Data was interpreted
with GeneMapper version 4.0.
SRY2 luciferase and cellular localization studies
The Sry responsive luciferase reporter, pGL3/AR600,
was produced by amplifying and inserting 590 bases of
5′ UTR from rat androgen receptor, isolated from a
single ♂SHR/y rat with primers 5′-GTA CCA TGG
TTT AGC TTG TCT CTA GCT TCC ACC-3′ and 5′-
CAC CCG GGT AAC TCC CTT TGG CTG A-3′.
Amplicons were cleaved using endonucleases NcoI and
SmaI, and the resulting restriction fragments were then gel
extracted and inserted into pGL3 vector (Promega) opened
with the same enzymes. Assembly of all native pEF1/Sry1,
2, and 3 effector constructs and truncated or site spe-
cifically mutated effector constructs was generated.
Chinese hamster ovary (CHO) cells were cultured at
37 °C in HAM’s F12K medium (Sigma-Aldrich, St. Louis,
MO) supplemented with 10 mM HEPES and 10 % FBS
(Atlanta Biologicals) in a humidified atmosphere with
5 % CO2. Prior to cotransfection, cells were seeded to
24-well cassettes (6.6 × 103 cells/cm2) and incubated for
16 h. Each well was transiently cotransfected with 50 ng
effector plasmid, 500 ng firefly luciferase reporter (pGL/
AR600), and 500 pg of control construct, phRL-null
Renilla (Promega), using SuperFect transfection reagent
(Qiagen, Venlo, Netherlands) following the manufac-
ture’s protocol. After 24 h incubation, CHO cells were
processed for luciferase activity using the reagents and
protocol provided in the Dual-Luciferase® Reporter
(DRL™) Assay System (Promega). Luciferase to Renilla
ratios were obtained from measurements collected on a
Turner Biosystems 20/20n luminometer and were used
to calculate pGL3/AR600 reporter activity of each Sry
effector construct relative to reporter activity obtained
from CHO transfected with an pEF1/Myc C vector con-
taining no insert. Data reported represent means ± SEM
of three trials conducted in triplicate with each Sry
effector construct. Statistical analysis was performed by
using one-way ANOVA and a post hoc Student-
Newman-Kuels test and Student’s t test where applic-
able. Analyses were run on SigmaStat software (Jandel
Scientific, San Rafael, CA) with significance assumed at
P < 0.05.
Various Sry constructs were created from Sry1 and
Sry2 pEF1 protein expression vectors to compare regions
that differ between Sry1, Sry2, and Sry3 proteins. These
constructs were Sry1(HMGbox)—Sry1 with only the
HMGbox, Sry1(delPolyQ)—Sry1 glutamine-rich region
converted to that of Sry2, Sry2(-QR)—removal of the en-
tire glutamine-rich region, Sry1(20-22AAA)—alanine
mutations to the N-terminal nuclear localization motif of
Sry1, Sry1(78-79AA)—alanine mutations to the C-terminal
nuclear localization motif of Sry1, Sry1(NoNLS)—alanine
mutations to both the N- and C-terminal nuclear
localization motifs of Sry1, Sry1(H21R)—histidine to argin-
ine mutation corresponding to the site seen in Sry2, and
Sry2(H21R)—histidine to arginine mutation corresponding
to the site seen in Sry1. CHO cells grown to approximately
1 × 105 cells/cm2 were transfected with 7.5 μg of each re-
spective plasmid DNA using ExGen500 transfection re-
agent (Fermentas), incubated for 24 h, trypsinized/pelleted,
and cytoplasmic/nuclear extracts were prepared using Pro-
teoJET Cytoplasmic and Nuclear Protein Extraction Kit
(Fermentas). Cytoplasmic and nuclear protein extracts
(20 μg) were separated on 13.5 % polyacrylamide gels.
Proteins were transferred to PVDF membranes that were
blocked for 1 h at room temperature in PBS containing
5 % nonfat dry milk and 0.1 % Tween-20. SRY proteins
where detected using a goat anti-mouse SRY (Santa Cruz
Biotechnology, Inc., Dallas, TX) or a goat anti-Myc epi-
tope (Bethyl Laboratories, Montgomery, TX) antibodies,
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diluted in a blocking solution at 1:300 and 1:1000, re-
spectively. After a 1-h incubation at 22 °C, blots were
washed in PBS, following a 1-h incubation with a don-
key anti-goat HRP conjugate (Bethyl Laboratories) di-
luted to 1:3000 in blocking solution. Bands were
detected using SuperSignal West Pico Chemiluminescent
substrate (Thermo Fisher Scientific Inc.) and visualized
with a Kodak 2200 Gel Logic Imaging system. All assays
included a control lane containing cell extracts obtained
from cells transfected with an expression vector contain-
ing no insert.
Protein modeling
Models for the nonHMGSry protein were generated
using the ab initio modeling server Quark [18]. Each of
the top five models were run for 10 ns of molecular dy-
namic simulations using YASARA with the Amber03
force field [19], 0.997 g/mL water, pKa of 7.4, and mass
fraction of 0.9 %. The Z-score, wrong isomers, and
cis-peptide bonds were calculated using the YASARA2
force field. Combining these calculations with the
analysis of movement throughout the molecular dy-
namic simulations, the models were ranked to deter-
mine the most likely structure. The nonHMGSry
protein sequence was also analyzed for functional mo-
tifs using ELM [20].
SRY-AR synergistic regulation assay
Luciferase assays on the Sry1 and AR600 promoters
were performed and analyzed as previously published
[21]. The SRY/AR synergistic regulation experiments
were performed using charcoal stripped fetal bovine
serum (Innovative Research, Novi, MI) with or without
the addition of 100 nM testosterone (Sigma-Aldrich).
The hSRY P131T corresponds to the variation seen in
SRY1 (P76) to SRY3 (T76) [22]. Androgen receptor (AR)
expression vector was purchased from ATCC (vector
#80005, hARa [CL7a-AR 160–910]). For each transfec-
tion, 100 ng of expression vector was used per well with
single protein expressions using 50 ng of vector (hSRY,
AR, or P73T) with 50 ng of empty vector and double
transfections (hSRY/P131T with AR) using 50 ng of
each. All constructs were sequence confirmed on an ABI
3130xl using BigDye Terminator v3.1.
Sry3 electroporation and blood pressure studies
A total of ten animals (normotensive WKY rats) were
used for three experimental groups. There were three
empty vector animals and seven Sry3-treated animals.
All of the empty vector animals and four of the Sry3
animals received drug treatment with olmesartan
medoxomil. Animals received a standard 12-h light/
dark cycle and were given standard rat chow (22.5 %
protein, 52 % carbohydrate, and 6 % fat by weight,
Prolab 3000, Agway, Syracuse, NY) and water ad libi-
tum. Rats were individually housed in polycarbonate
cages (48 cm× 27 cm× 20 cm) with heat‐treated bedding
(Sani Chips, R.J.Murphy, Rochelle Park, NJ). Cage changes
were performed once a week, scheduled so as not to inter-
fere with blood or urine sampling.
Animals were implanted with an aorta telemetry device
(model-PAC40; Data Sciences International, St. Paul, MN),
and baseline measurements of systolic pressure, diastolic
pressure, heart rate, and activity were collected (RPC-1 and
Dataquest A.R.T., Data Sciences International). All animals
were monitored for telemetry measurements throughout
the study, at 30‐min intervals, except for the 24‐h periods
that animals spent in metabolic cages. Animals were
allowed to recover from telemetry surgery for 1 week be-
fore a baseline metabolic cage study was done.
All animals were injected and electroporated with
PEF1(−) or PEF1/Sry3 (25 μg) into the left kidney as pre-
viously performed [23], which represents day 1 of the
study. On day 6, the first 24‐hour urine was taken
followed by the first plasma sample on day 8. On day 14,
animals were given sham- or olmesartan-treated drinking
water. The drug was given for 1 week total, and on day 17,
a second 24‐h urine was taken followed by a second
plasma on day 19. Drug treatment was then stopped and
time was given to allow the drug to leave the system. On
day 25, a final 24‐h urine was collected followed by a final
plasma sample on day 27. All the above animal experi-
ments were approved by the University of Akron IACUC.
Phenotype analysis of BNxFHH and BNxSS consomic panels
The chromosome-Y consomic rats were generated as part
of the PhysGen Program for Genomic Applications
(http://pga.mcw.edu). Detailed phenotyping protocols are
posted on the website. Briefly, six phenotyping protocols
(Lung, Respiratory, Cardiac, Renal, Vascular, Biochemistry)
were run in parallel using ten male and ten female rats
per protocol. Rats were studied between 6 and 10 weeks
of age and under control conditions or under diet or en-
vironmental stress. The consomic rats were studied
using the same protocols and quality controls as pre-
viously described [24]. Phenotypes listed to significantly
differ were determined using adjusted P values <0.05 in
the consomic strain (for example SS-YBN/Mcwi) com-
pared to the parental strain (for example the SS). The
adjusted P values were calculated by the Mann-Whitney
test followed by a Bonferroni adjustment for multiple
tests. All animal experiments were approved by the
Medical College of Wisconsin IACUC.
Results
Mammalian conserved protein-coding genes in rat
Of mammalian conserved MSY genes, nine (Eif2s3y, Zfy,
Usp9y, Ddx3y, Uty, Ube1y, Kdm5d, Rbmy, Sry) are
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confirmed in rat [2] and thus would be primary MSY
genes of interest in translatable human disease. All nine
conserved genes are expressed in rat testis, with five
genes (Eif2s3y, Ddx3y, Uty, Kdm5d, and Sry) expressed
in all ten male tissues of the Rat BodyMap project
(Table 1). Sry is well known to have undergone gene du-
plication, with variants defining 11 genes: Sry1, Sry2,
Sry3, Sry3A, Sry3B, Sry3BI, Sry3BII, Sry3C, Sry4, Sry4A,
and nonHMGSry [21]. Most of these SNPs for individual
Sry genes could be mapped onto the rat MSY sequence
relative to other human shared genes (Fig. 2a).
Autosomal gene duplications onto the rat MSY
While identifying Sry copies in the SHR MSY sequence,
we found transposable elements were likely causal for
duplication of Sry genes and also identified two non-
MSY genes, Med14Y and Limd2Y, that have been dupli-
cated from the X chromosome and autosomes onto the
rat MSY [21]. However, the confirmation of these and
other duplicated genes onto rat MSY is difficult due to
repetitive sequence. To confirm duplicated genes, we
developed a novel sequence analysis, comparing variants
of genes identified in males but not females, using
whole-genome sequencing.
The absolute sex for all reads of 23 sequenced rat ge-
nomes was determined, identifying Sry sequence reads
in 18 genomes; thus, only 5 genomes are 100 % female
DNA (Additional file 1: Table S2). This approach allows
for Sry-contaminated female sequences to be treated as
males, thus treating SNPs of duplicated genes of males
that could also be included with equal probability as Sry
sequence. Following alignment of reads to the Rnor 5.0
genome (lacks MSY sequence), all single-nucleotide vari-
ants (SNVs) found in protein-coding genes of male ge-
nomes and not female genomes identified a subset of
genes potentially inserted onto MSY (Table 2). Nine
genes are found to have specific SNVs in all 18 male rat
genomes with an average allele frequency of 30.7 % over
2790 SNVs, close to the 33 % expected frequency for a
variant found in an autosomal gene that has been dupli-
cated onto the MSY. The duplicated Limd2 was con-
firmed by this analysis for all strains; however, Med14
was not. Removing individual male genomes from the
analysis, we were able to identify strain-specific variants
in male duplicated genes, such as the lack of 33 Med14
SNVs in the FHL rat strain, suggesting this gene is not
present in the FHL MSY.
Clustered male-specific SNVs from the analysis above
(two or more SNVs located within 20 bases), allowing
for single-read detection of multiple variants found
throughout male rat strains, were used to screen MSY
bacterial artificial chromosomes (BACs) and also the Rat
BodyMap datasets. Each of the specific SNV sites was
detected in SHR MSY sequencing BACs (Table 1), con-
firming with a secondary sequencing approach the exist-
ence of the duplicated genes into the MSY. This
identification on MSY BACs also allowed for a predic-
tion of the mechanism of duplication. Seven genes were
identified as retroposed (i.e., spliced genes reinserted
onto MSY), one as a MSY gene that duplicated to an
autosome (RGD1560580) and two as transposed genes
(i.e., contains normal introns of gene). Using the Rat
BodyMap dataset in combination with the male-specific
SNVs, expression was detected for only two retroposed
genes, Med14Y (Fig. 2b) and Ube2q2Y (GenBank
KM610331, Fig. 2c), in male and not female RNAseq
datasets.
Med14Y (Fig. 2b) and Ube2q2Y (Fig. 2c) are expressed
in all male but not female tissues of the Rat BodyMap
dataset, with their MSY location shown on Fig. 2a. In
comparison to Med14Y and Ube2q2Y, Limd2Y has only
three detectable reads out of the 13.3 billion analyzed
and also contains one mutation resulting in the deletion
of a Zn coordination site required for structural folding
[25] and additional nonsense mutations (Additional file 1:
Figure S1). The combination of a lack of transcription and
mutations that would inhibit protein function suggests
that Limd2Y has become a pseudogene (Limd2Y-ps) on
rat MSY in all sequenced male strains. Initial analysis
of our rat variant visualizer tool, based on Rnor 3.4
genome alignment lacking MSY sequence, on the rat
genome database (http://rgd.mcw.edu/rgdweb/front/
config.html) for all strains showed that these variants
for all autosomal genes inserted into the MSY were
present at around 1/3 allele frequency in the data-
base. This suggests a possibility of researchers to mis-
identify MSY gene variants as heterozygous variants
in autosomal genes.
To update this information and add ChY gene vari-
ants between strains, a new strain genome compari-
son tool was created. We sequenced male genomes
for seven strains (ACI, FHH, FHL, SBH, SBN, SR, SS)
and aligned them onto the Rnor 6.0 assembly that
Table 1 Conserved Y chromosome genes found in rat




EIF2S3Y GATN01000003.1 AC242953.5 Ubiquitous
ZFY GATN01000010.1 AC239865.4 Testis
USP9Y GATN01000001.1 AC242055.4 Testis
DDX3Y GATN01000002.1 AC242055.4 Ubiquitous
UTY GATN01000009.1 AC241873.4 Ubiquitous
UBE1Y EF690356.2 AC242953.5 Testis
KDM5D GATN01000004.1 AC242859.2 Ubiquitous
RBMY GATN01000006.1 AC239817.2 Testis
SRY Multiple AC239701.6 Ubiquitous
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includes newly sequenced MSY. The number of
single-nucleotide variants (SNVs) was calculated for
each strain and was made relative to total chromo-
some size (Additional file 1: Table S3). The analysis
shows a 1.98 ± 0.06-fold elevation of SNVs on MSY
relative to all other chromosomes (Fig. 2d), a value
that is similar with previous rodent MSY sequencing
work [26] confirming MSY wide rate in nearly every
analyzed rat strain. To resolve this issue with variant
analysis, we have developed and released a new Variant
Visualizer from the rat genome database (http://
rgd.mcw.edu/rgdweb/front/config.html?mapKey=360) for
variants called from Rnor 6.0 alignment for seven different
rat strains.
Fig. 2 Rat MSY genes. a Alignment of the various genes described in this paper onto the RNor 6.0 MSY sequence of Rattus norvegicus. Retroposed
genes that align onto the sequence are shown on the top. Ubiquitously expressed genes in the Rat BodyMap dataset are colored in purple while
tissue-specific genes are in black. b, c Expression profiling for the F344 Rat BodyMap dataset for Med14Y (b) and Ube2q2Y (c) in multiple tissues of male
and female animals. Expression is shown as the number of reads for MSY copy (Med14y/Ube2q2y) divided by X (Med14y) or chromosome 8 (Ube2q2)
and Y copies, in such that values of 0.5 are a 50/50 ratio of transcripts from the X/8 and MSYs and a value of 0 is expression from only
the X/8-chromosome. Error bars represent the error of four independent RNAseq datasets and asterisk represents a P < 0.05 between male and female
rats. d Distribution of SNPs detected in seven male rat strains on the genome. SNP counts on the y-axis of box-and-whisker plot are normalized to the
chromosome size in Mb. MSY (red) is shown to have highly elevated number of mutations compared to all other chromosomes
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Sry duplicated genes in commonly used rat strains
Sry is expressed in numerous human tissues [3]. An
overlap of many tissues, such as kidney, is seen for the
expression of Sry in primates and rat that are not found
in the mouse [27]. This expression is novel to Sry as it is
not seen for Sox3, the ChrX homolog of Sry [27]. How-
ever, the expression profile of rat Sry is ubiquitous while
in human it is not [3]. Unlike the human genome,
the rat genome contains 11 functionally distinct
copies of Sry (http://bmcgenomics.biomedcentral.com/
articles/10.1186/1471-2164-14-792) likely amplified
through gene conversion at repetitive elements [21].
The existence of these 11 copies has only been per-
formed in two strains to date (SHR and WKY), and
an expression profile for each copy has never been
performed in detail before. Thus, the overlapping
function between Sry in rat and human would be bet-
ter understood by a copy-specific expression analysis
in multiple laboratory strains of rats.
The advancing technology of next-generation sequen-
cing allows for the identification of multiple Sry genes at
sequence resolution in both genome and transcriptome,
further enhancing our capabilities in segregating mul-
tiple Sry copies. Utilizing SNVs (Fig. 3a) unique to spe-
cific copies of rat Sry (protein shown in Fig. 3b), 8 of 11
Sry copies are confirmed in SHR, WKY, FHH, FHL, SR,
SS, and F344 inbred rat strains (Fig. 3c). The remaining
Sry3 copy is unable to be differentiated (nd, not deter-
mined) from Sry3BI/3BII due to short reads used in
next-generation sequencing. Our initial work using real-
time PCR (Fig. 3d) confirms Sry multiple tissue expres-
sion in the rat; however, now that we have established
the existence of at least 8 Sry copies in the majority of
commonly used rat strains, a more detailed analysis of
Sry copies expression is needed.
A fragment analysis protocol was initially developed to
identify copy expression specificity, particularly for the
Sry2 gene. Using this approach, Sry2 is observed to have
the highest expression of Sry copies in most tissues [17];
however, this approach is limited to the analysis of only
a few Sry copies that have variants altering restriction
sites. The Rat BodyMap dataset allows, for the first time,
the ability to assess expression of each Sry copy in mul-
tiple tissues (Fig. 4a). In agreement with our SHR and
WKY fragment analysis, Sry2 is the predominantly
expressed copy throughout all tissues. To assess Sry ex-
pression in other rat strains, we utilized publically avail-
able RNAseq datasets in NCBI. Sry transcripts are
detected in 197 separate rat RNAseq datasets; however,
only 15 of these datasets contain transcripts that are
from non-Sry2 copies (Fig. 4b). This Sry2 copy, found so
ubiquitously transcribed, is located within an intron, in
the antisense orientation, of the ubiquitously expressed
Kdm5d gene (Fig. 2a) suggesting the location of the gene
insertion has possibly driven elevated expression. Likely
to compensate for this elevated expression, SRY2 rapidly
accumulated an amino acid mutation (H21R) within the
N-terminal nuclear localization site (nNLS) that alters
the ability of SRY2 to activate transcription (Fig. 4c) and
localize the protein within the nucleus (Fig. 4d, e). Add-
itionally, we have previously shown that SRY2 variants
located in the glutamine-rich region (deletion of 13
amino acids corresponding to changes in Sry2 location
in SDS-PAGE of Fig. 4d) decrease transcriptional control
[21]; however, these mutations and the complete re-
moval of the glutamine-rich region (Fig. 4d, lane 4) do
not alter nuclear localization (Fig. 4d), only transcrip-
tional control.
Of the tissues analyzed from the Rat BodyMap and
publically available RNAseq datasets, the testis, kidney,
lung, spleen, brain, and colon show expression of non-
Sry2 copies. Interestingly, the list of rat tissues express-
ing non-Sry2 genes (all Sry genes excluding Sry2) over-
laps nearly perfectly with our previous analysis of the
Table 2 Autosomal gene duplication to MSY












chr2 Ect2 25 23.9 ± 2.3 – SBH(2), SR(2), SS(1) AC241473.5 Ect2Y_ps Retroposed None
chr8 Ube2q2 16 20.6 ± 2.1 – LL(2) AC241873.4 Ube2q2Y Retroposed Ubiquitous
chr10 Havcr2 33 30.8 ± 2.3 – – AC241887.5 Havcr2Y_ps Retroposed None
chr10 Limd2 40 45.2 ± 2.9 – LH(1), SBN(1) AC241808.7 Limd2Y_ps Retroposed None
chr12 RGD1560580 4 24.9 ± 4.5 – – AC241548.6 Ssty2 MSY duplication None
chr13 Xpr1 24 28.9 ± 2.1 – F344(2), SBN(1) AC246656.3 Xpr1_Y1/2/3/4 Transposed None
chr13 Prrc2c 2 19.6 ± 1.8 – – AC241950.2 Prrc2cY_ps Retroposed None
chr14 Vom2r67 5 24.4 ± 2.7 – SBH(2), SR(1) AC242505.8 Vom2rY_ps Retroposed None
chr16 Lsm1 5 24.9 ± 2.2 – – AC243283.4 Lsm1Y_ps Partial transposed None
chrX Med14 33 31.2 ± 3.3 FHL FHH(1) AC239701.6 Med14y Retroposed Ubiquitous
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human protein atlas expression profile for human SRY
[3]. The lung contains a vast array of Sry copies (Fig. 4a)
including the highly conserved nonHMGSry (GenBank
KC215141.1) that contains a frame shift mutation dir-
ectly before the high-mobility group (HMG) domain,
but still codes for an open reading frame. This is the first
time transcripts from nonHMGSry have been identified.
Protein modeling, molecular dynamic simulations, and
functional motif analysis of this novel protein elucidate
regions of structural order, possible nuclear localization
motif, 14-3-3 binding motif, and a degradation box sug-
gesting functional impact for transcripts from this rat
conserved gene (Additional file 1: Figure S2).
Mapping of genes in MSY consomic SHR to WKY
crosses (Fig. 1) resolved that the SHR rat has a duplica-
tion of an Sry3 gene relative to other analyzed strains
[28]. The cross of the SHR/y consomic animal to the
Tfm rat model (Fig. 1) blocks MSY blood pressure eleva-
tion, suggesting that there is interplay between the Sry3
locus and AR signaling. SRY has previously been shown
to directly bind AR protein [29]. The SRY3 protein con-
tains an amino acid substitution (proline to threonine)
at amino acid 76. Furthermore, we have shown that SRY
and AR can synergistically regulate promoters in a
testosterone-dependent manner and that a change from
a proline to threonine in SRY results in a loss of this
synergistic promoter regulation with AR (Fig. 5a). This
threonine point mutation has also been shown to in-
crease regulation of the renin-angiotensin system (RAS)
components to elevate the pro-hypertensive angiotensin
II peptide in vitro [22] and in vivo [23]. Sry3 copies
(Sry3, Sry3A, Sry3B, Sry3BI, Sry3BII) are expressed in rat
(Fig. 4a) suggesting that these Sry3 genes may have a
kidney function through regulation of the RAS. Delivery
of a Sry3 expression vector to the normotensive WKY
rat results in a blood pressure elevation that can be
blocked with a RAS inhibitor, olmesartan (Fig. 5b). This
finding supports Sry3 gene duplication within SHR caus-
ing altered testosterone signaling and regulation of the
renin-angiotensin system. In light of preliminary data for
Fig. 3 Characterization of the multiple Sry copies in commonly used rat strains. a Schematic breakdown of the domains found in rat SRY showing the
N-terminus (red), HMG box (blue), hinge (green), bridge (magenta), and C-terminal (yellow) domains of the protein. Locations of SNVs that allow for the
identification of individual copies based on the known SHR sequence are shown below the schematic. b Protein model of the full rat Sry1 protein
bound to DNA (gray). Color scheme from a for the various domains are shown on the model. c Detection of the SNVs for the multiple copies of Sry
from the genomic sequence reads for multiple male rat strains (SHR, WKY, FHH, FHL, ACI, SR, SS, and F334). The plus sign represents multiple reads with
100 % homology (red boxes), the minus sign represents those with no positive SNVs detected (no color), and nd are copies of Sry that do not contain
SNVs allowing for identification using short reads. d–f Real-time PCR of Sry from five tissues for WKY (d), SHR (e), or the SHR/y consomic (f)
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the overexpression of human SRY within the rat kidney,
this suggests a high probability of SRY involvement in
blood pressure regulation and potentially hypertension,
with the rat serving to provide mechanistic understand-
ing of SRY within the kidney.
MSY of other rat strains contributes to phenotypic
diversity
Identifying genes in the MSY that contribute to pheno-
types such as blood pressure in the rat suggests the need
for a broader phenotyping analysis of MSY contribution.
Fig. 4 Expression and function of Sry copies. a Analysis of Sry transcripts (as reads per million sequence reads that contain identifying SNP) from
the Rat BodyMap datasets for multiple tissues of males and a control female uterus tissue. Colors correspond to the Sry identifying SNP; Sry1= blue,
Sry2 = red, Sry3’s = green, Sry4’s = cyan, nonHMGSry =magenta. b Analysis of publically available rat RNAseq datasets (excluding the Rat
BodyMap datasets) for the SNVs of Sry2 (x-axis) vs. the other non-Sry2 copies (y-axis). Tissues with the highest expression of non-Sry2 copies
are labeled in red. c Differences in transcriptional regulation by the SRY2 protein. Alanine mutations to nuclear localization site of Sry1 (Sry1
20-22A) results in a loss of promoter regulation (red). Mutating amino acid 21 from His (found in Sry2) to an Arg (found in Sry1 and Sry3) in
the SRY2 protein results in a significant elevation of promoter activity (blue) relative to Sry2. d, e Nuclear localization of Sry constructs shown as Western
blot for multiple Sry constructs (d) or quantification of western blot for several constructs (e). For panel d, Lane 1 = Sry1(HMGbox), 2 = Sry1(delPolyQ),
3 = Sry2, 4 = Sry2(−QR), 5 = Sry1, 6 = Sry3, 7 = Sry1(20-22AAA), 8 = Sry1(78-79AA), 9 = Sry1(NoNLS), 10= Sry1(R21H), 11= Sry2(H21R), 12= negative control
(empty vector)
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As part of two large systematic rat consomic panels
created and phenotyped by our PhysGen Program for
Genomic Applications [13, 14], data for MSY consomic
rats provides the first large-scale phenotyping for MSY
contributions. Phenotypes were measured on consomic
FHH-YBN/Mcwi (BN MSY introgressed onto FHH
genomic background) and SS-YBN/Mcwi (BN MSY
introgressed onto SS genomic background). In FHH-
YBN/Mcwi and SS-YBN/Mcwi, 131 and 223 phenotypes
respectively were measured. When comparing values
for FHH-YBN/Mcwi to male FHH rats, 28 phenotypes
are significantly different (Additional file 1: Table S5).
When comparing values for SS-YBN/Mcwi to male SS
rats, 29 phenotypes are significantly different (Additional
file 1: Table S6). As a percent of total phenotypes observed
to be significantly different in the consomic relative
to parental strain per megabase (Mb) of DNA, MSY
has a 36.09 ± 3.84-fold (47.23 ± 6.17-fold in BNxFHH
and 24.95 ± 3.05-fold in BNxSS) higher contribution
to phenotypes than any other chromosome consomic
generated (Fig. 6a). Although chromosome size of the
MSY differs between rat strains [12], there has yet
been evidence of non-MSY sequence driving the
changes in size; thus, the genes present in the se-
quenced SHR are also likely to drive the phenotypes
altered by MSY consomics through either copy num-
ber variants or SNVs. This is the first evidence that
many broad phenotypes in rat lab strains reflect, at
least in part, MSY variation.
Additional analysis of MSY contribution can be ob-
served by comparing male to female phenotypes for a
particular strain. From the 28 FHH-YBN/Mcwi and 29
SS-YBN/Mcwi significant phenotypes, the difference be-
tween male to female parental animals (BN, FHH, and SS)
was calculated for each phenotype (Table 3). Of the traits
seen significantly altered in FHH-YBN/Mcwi, 15 pheno-
types show a significant sex difference in both FHH and
BN, while only 2 phenotypes show FHH sex specific dif-
ferences and 10 phenotypes show BN sex-specific differ-
ences (Fig. 6b and Table 3). Of the phenotypes seen
significantly altered in SS-YBN/Mcwi, 22 phenotypes show
sex differences in both SS and BN, while 1 phenotype
shows SS sex-specific difference and 3 phenotypes show
BN sex-specific differences (Fig. 6b and Table 3).
There were two traits that overlapped in both MSY
consomic rats that have a BN sex-specific difference, di-
lator response to acetylcholine EC50, and dilator re-
sponse to acetylcholine Log EC50. With male BN rats
having a higher response than female rats, it is surpris-
ing that FHH-YBN/Mcwi (Fig. 6c) and SS-YBN/Mcwi
(Fig. 6d) significantly decrease the response relative to
either FHH or SS. The large sex difference in the BN rat
migrates only with chromosome 15 between the two
consomic panels, FHH-15BN/Mcwi and SS-15BN/Mcwi,
Fig. 5 SRY blood pressure regulation through androgen receptor and the renin-angiotensin system. a Testosterone-dependent synergistic
regulation between SRY and AR is altered by mutations to SRY at the location that separates Sry3 (T) and all other rat and mammalian
SRY sequences (P). b Delivery of the Sry3 expression vector (open circle) to the kidney of WKY male rats at day 0 significantly increased blood pressure
relative to a control (closed circle) 14 days after vector electroporation. Olmesartan, a RAS inhibitor, administered to control and half of the Sry3-treated
animals (closed triangle) at day 14, significantly decreases blood pressure to the same value in both groups. Following removal of olmesartan at day 17,
blood pressure increased more rapidly in the Sry3-treated group (closed triangle). Error bars are shown as the SEM of three to four independent animals
with asterisk representing a P < 0.05 for blood pressure between the Sry3 and control vector electroporated animals
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suggesting chromosome 15 is responsible for BN-
specific sex difference in acetylcholine response, but
MSY may have evolved to partially attenuate this re-
sponse in the BN rat (Fig. 6d, e).
Discussion
Few animal models currently exist to study the contribu-
tions of MSY to phenotypes, which could contribute to
narrowing down genes that contribute to human disease.
Fig. 6 High-throughput phenotyping of two consomic panels in the rat. a The percent of significantly altered phenotypes due to crossing each
chromosome in two separate consomic panels (BN to FHH in black and BN to SS in red) shown per megabase (Mb) or per ten genes of the
chromosome. b Phenotypes identified in a to be significantly altered by the two MSY consomic rats (FHH-YBN/Mcwi in black and SS-YBN/Mcwi
in red) were then separated based on if a significant difference between males and females was also seen for one or both strains used to produce
the consomic rat. Phenotypes that had a sex difference in one specific strain are listed in each category. Two phenotypes were identified to
overlap in the two consomic rats with a BN-specific sex difference, dilator response to acetylcholine EC50 and dilator response to acetylcholine
Log EC50. c, d The dilator response to acetylcholine EC50 for male (black) and female (gray) BN and FHH (c) or SS (d) rats showing BN to
have the largest sex difference. MSY consomic significantly decreased the response in both FHH (c) and SS (d) consomic rats (red). The
chromosome 15 consomic rats (FHH-15BN/Mcwi and SS-15BN/Mcwi) resulted in a greater sex difference for both strains. Error bars represent
the SEM of independently tested rats and asterisk represents an adjusted P value <0.05 calculated with Mann-Whitney test followed by a
Bonferroni adjustment
Prokop et al. Biology of Sex Differences  (2016) 7:10 Page 12 of 16
Table 3 MSY altered phenotypes with differences in male to female rat strains








Plasma lymph abs (E3) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi No Yes –
Plasma segmented neutrophils (E3) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi No Yes –
Plasma mean corpuscular hemoglobin content (pg) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes No –
Plasma mean corpuscular volume (fL) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes No –
Plasma red blood cell (E6/μL) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes No –
Pre-ischemic heart wet weight (g) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes No –
Pre-ischemic heart wet weight (g) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes No –
Pre-ischemic left ventricle developed pressure (mmHg) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes No –
Pre-ischemic left ventricle systolic pressure (mmHg) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes No –
Methacholine ED50 (mg/kg) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes No –
Dilator response to acetylcholine EC50 (E-7 mole) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes No –
Dilator response to acetylcholine Log EC50 (Log molar) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes No –
Plasma alk phos (U/L) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Plasma globulin (g/dL) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Plasma hematocrit (%) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Plasma hemoglobin (g/dL) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Plasma phosphorus (mg/dL) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Plasma total protein (g/dL) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Plasma white blood cell count (E3/μL) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Ischemic peak contracture (mmHg) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Body weight (kg) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Body weight (kg) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Body weight (kg) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Lung dry wt (g)/body wt. (kg) ratio (g/kg) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Hematocrit (%) 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Rt ventricle/left ventricle weight ratio (w/w ratio) 12 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
Body weight 21 % O2, 0.4 % salt, male FHH-YBN/Mcwi Yes Yes –
r @flow = 100 ml/min/g (mmHg ×min × kg ×ml−1) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi No – Yes
Plasma red blood cell (E6/μL) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – No
Dilator response to acetylcholine EC50 (E-7 mole) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – No
Dilator response to acetylcholine Log EC50 (Log molar) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – No
Plasma calcium (mg/dL) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Plasma globulin (g/dL) 21 % O2, 0.4 % Salt, Male SS-YBN/Mcwi Yes – Yes
Plasma globulin (g/dL) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Plasma hematocrit (%) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Plasma hemoglobin (g/dL) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Plasma hemoglobin (g/dL) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Plasma mono abs (E3) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Plasma potassium (mmol/L) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Plasma red blood cell (E6/μL) 12 % O2, 0.4 % Salt, Male SS-YBN/Mcwi Yes – Yes
Plasma total protein (g/dL) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Ischemic time to onset of contracture (s) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Ischemic time to peak contracture (s) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Pre-ischemic heart rate (beats/min) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Pre-ischemic heart wet weight (g) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
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Although many new tools are emerging to study human
genetic-to-phenotype associations (such as iPS, organoid
culturing, CRISPR/Cas9, and patient cell analysis),
studying complex multi-tissue phenotypes and the ability
to identify causal variants/genes to disease in a large
genomic environment of thousands of inherited variants
(such as the MSY) seen in the human still requires ani-
mal models. This paper set out to begin defining rat
MSY genes in several commonly used rat strains to
create models to study MSY variant contributions to
phenotypes. The SHR MSY consomic rat (Fig. 1) has
served as a model organism for studying the contribu-
tion of MSY genes, such as the SHR-specific Sry3 gene
[28], in cardiovascular phenotypes. We have shown in
this paper that the protein product of Sry3 can alter an-
drogen receptor synergistic feedback and that delivery
into the rat kidney results in pronounced blood pressure
elevation that is blocked by a RAS inhibitor. This sug-
gests a molecular mechanism into the repression of
blood pressure response seen in the SHR/y cross to the
Tfm rat, showing a synergistic response between MSY
genetics and hormone signaling. Our identification of a
relationship between genetic variation in rat Sry and blood
pressure through the RAS promises to facilitate further
studies of such a potential mechanistic link between hu-
man SRY and blood pressure regulation [22, 27].
Previous data for Sry in both rat and mouse suggest
that the gene contributes to diverse phenotypes such as
brain development [30] and that MSY genes in the
mouse contribute to a number of phenotypes [3]; how-
ever, a large-scale phenotyping project has not yet been
performed for any consomic animal strains before this
paper. In this paper, we have shown that MSY per DNA
base has a large phenotypic diversity between rat strains,
a likely result of being a region within the genome to
have uncontrolled mutations in inbred mating due to a
lack of genetic crossover to remove de novo variants.
This also highlights the importance of maintaining no-
menclature on isolated breeding of strains, as MSY con-
tinues to diverge in separate mating locations and can
result in different phenotypes based on mating location.
This concept is supported by work in comparing the
SHR/Akr MSY consomic with the SHR/Crl consomic,
which lacks the Sry3 duplication that results in blood
pressure elevation [28] and thus lacks a blood pressure
association [31]. This paper would also suggest a poten-
tial importance of mitochondrial genomics, as many of
the inheritance patterns for that region would be under
similar evolution as MSY in inbred animals; however,
few studies have focused on this to date.
Furthermore, we have shown the expression profile for
nine MSY genes found in rat and human. Using whole-
genome sequencing reads from male rats, seven copies
of Sry have been confirmed for the first time in multiple
commonly used laboratory rat strains. The only Sry copy
found ubiquitously expressed, Sry2, was inserted into an
intron of the antisense strand of the ubiquitously
expressed Kdm5d gene and also contains mutations
damaging to nuclear localization and transcriptional
regulation. With initial fragment analysis protocols only
amplifying Sry2 in an orientation-dependent manner,
without amplifying Kdm5d introns, the high expression
of Sry2 is likely driven by global chromatin state around
the Kdm5d gene and is not transcripts detected from
Kdm5d intron background of RNAseq. This highlights
the fact that the location of genomic insertion can drive
an expression profile; however, instead of being able to
select on the removal of the gene as would be done on
autosomes, MSY sequence has likely been selected on to
remove functionality of the protein, maintaining future
bulk of MSY contrary to previous MSY degradation the-
ories. Other functional Sry copies are found expressed in
specific tissues including the testis, kidney, lung, and
spleen, similar to the expression profile of human SRY.
This suggests that “undifferentiated” Sry gene copy ex-
pression data (generated by techniques such as real-time
PCR) biases the understanding of specific Sry copies,
with the use of sequencing-based technologies or our
fragment analysis protocol (can separate out Sry2 from
other copies), a more reliable method for Sry expression
analysis in future rat work.
The technique of identifying male-specific variants in
duplicated genes, although utilized here only in rat,
could be used in the future to identify additional
Table 3 MSY altered phenotypes with differences in male to female rat strains (Continued)
Body weight (kg) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Body weight (kg) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Lung dry wt (g)/body wt. (kg) ratio (g/kg) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Hematocrit (%) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Hematocrit (%) 12 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Body weight (kg) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
Rectal temperature after hypercapnia (°C) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
% maximum relaxation acetylcholine (%) 21 % O2, 0.4 % salt, male SS-YBN/Mcwi Yes – Yes
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mammalian species-specific duplications onto MSY. The
assembly of MSYs from several mammals has elucidated
duplication events such as CDY [32], FLJ36031Y [33],
ZNF280AY [34], and MBTPS2Y [1]. However, with only
a handful of sequenced MSYs in mammals, the extent of
such gene duplications throughout mammalian evolu-
tion is unknown. The technique shown here is capable
of identifying MSY duplications from reads of several
male (or male-contaminated female samples) and female
whole-genome sequences, a task that has become rela-
tively inexpensive with next-generation sequencing
technologies.
Gene duplication has been recognized as a driver of
phenotypic changes for human diseases [35]. Studying
duplication of autosomal genes onto MSY provides a
unique opportunity to understand mechanisms and se-
lective pressure of gene duplication, in addition to asses-
sing the current status of our genomic scaffold. Of seven
duplication events detected in our work, only two genes
were found as expressed transcripts, with five becoming
pseudogenes. Of the two genes that maintain expression,
it is shown that Med14y was not present in rat strains
such as FHL. Duplication of Ube2q2, a gene associated
with kidney function [36], onto MSY was initially con-
sidered a pseudogene in SHR sequence annotation [2].
However, when analyzing the F344 sequence, transcripts
were found ubiquitously expressed from MSY (using the
male-specific SNVs). Analysis of 197 male RNAseq data-
sets from the rat identified 35 additional RNAseq data-
sets to have detectable Ube2q2Y transcripts, suggesting
strain-specific stratification in expression. The repetitive
nature of rat MSY has made it challenging to generate a
complete MSY sequence for rat. The analysis of Sry and
autosomal gene duplications on MSY can serve as
markers for completeness of our current assemblies. For
example, the SNVs found in Sry3C or pseudogenes
Ect2Y_ps, Havcr2Y_ps, Prrc2cY_ps, and Vom2rY_ps,
which have been confirmed in multiple male rat ge-
nomes, are not found in the current Rnor 6.0 MSY as-
sembly. These therefore serve as valuable markers in the
future for completing a rat MSY sequence.
Conclusions
Tools to genetically modify rat strains are rapidly in-
creasing in use [37], allowing for the assessment of a
single-gene modification in the vast array of genetic
landscapes [15] present in rat research. Identification
and characterization of rat MSY genes in this paper
opens the door for rat MSY gene editing to study sex dif-
ferences in diseases. Hopefully, this approach can narrow
down the large haplotype block of human MSY to spe-
cific genes that contribute to disease association and also
suggest approaches that can be used for other species
(mouse and primates) to study future MSY phenotype
contributions. We now have a causal relationship estab-
lished in the SHR MSY for the Sry gene to cardiovascu-
lar disease, allowing for focus on human variants in
MSY haplotype groups associated with cardiovascular
disease to the SRY gene regions, while also implicating
AR signaling to influence blood pressure control
through SRY synergistic transcriptional regulation.
Utilizing a new male/female SNV segregating approach
based on whole-genome sequence reads, we have shown
a promising new technique in identifying gene duplica-
tions onto MSY that may be critical in identifying
species-specific duplication events. Two (Med14Y and
Ube2q2Y) functional MSY retroposed genes (out of ten
duplication events shared in most rat strains analyzed)
are shown in this paper to have strain-specific variation.
The strain-specific outcomes of these duplication events
and the high mutation rate of MSY in inbred rat popula-
tions suggest a major concern, particularly in light of the
phenotypic role MSY is shown to have in this paper.
Two consomic panels of inbred rats show MSY to con-
tribute 36-fold more per chromosome size to inbred
strain phenotypes than any other chromosome in the rat
genome. The combination of approaches taken in this
paper to analyze rat MSY genes highlights the import-
ance of MSY to phenotype/disease, suggesting inbred
models such as rat are ideal to dissect mechanisms of
human MSY genes involved in sex differences. Once
gene-to-phenotype relationships are established for these
animal models, we envisage that the research commu-
nity might exploit CRISPR/Cas9 modification of human
cell lines to investigate relationships between human
MSY variants to disease states.
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